• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    More On CYCCP

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Cyclacel Pharmaceuticals, Inc. (CYCCP)

    -NasdaqCM
    7.75 Down 0.25(3.12%) Feb 27, 1:06PM EST
    Add to Portfolio
    Prev Close:8.00
    Open:7.65
    Bid:7.05 x 700
    Ask:7.75 x 100
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:7.00 - 7.75
    52wk Range:3.50 - 9.70
    Volume:5,280
    Avg Vol (3m):953
    Market Cap:178.06M
    P/E (ttm):N/A
    EPS (ttm):-0.88
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):102.91
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Cyclacel Pharmaceuticals, Inc., a development-stage biopharmaceutical company, develops and commercializes mechanism-targeted drugs to treat human cancers and other serious diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback